Aurobindo Pharma specializes in the development and manufacture of generic pharmaceuticals and active pharmaceutical ingredients. The company targets a diverse range of customer segments, including healthcare providers and pharmacies, offering products in key therapeutic categories such as antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics.
2024 Revenue: Approximately $3 billion
Employees: 16,000
Aurobindo is one of the...
Aurobindo is a company listed under the stock ticker AUROPHARMA (IN).
Aurobindo has a direct presence in 3 countries.
They are in:
View the org chart displaying its 24 main executives
Create your alert
to follow the executive moves at Aurobindo.
Aurobindo has 1,828 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.